From the Departments of Physiology (Z.Z., W.J.A.) and Pathology (S.H.Z.,
N.M.), University of North Carolina at Chapel Hill; the Department of
Medicine, Duke University, Durham, NC (T.C.), and the Institute of Physiology,
University of Regensburg (Germany) (C.W., A.K.).
AbstractOur studies on
angiotensin II receptor subtype 1A (AT1A)
knockout mice define how endogenous receptors other than
AT1A receptors stimulate changes in cytosolic calcium
concentration ([Ca2+]i) in cultured aortic
vascular smooth muscle cells (VSMCs). Wild-type cells have a 1.7 ratio
of AT1A/AT1B receptor mRNA as determined by
semiquantitative reverse transcriptasepolymerase chain reaction.
Mutant cells express AT1B receptor mRNA but not that for
the AT1A receptor. In wild-type cells with AT1A
present, Ang II (10-7 mol/L) produces a characteristic
rapid peak increase in [Ca2+]i of 150 to 180
nmol/L, followed by a plateau phase characterized by a sustained 70 to
80 nmol/L increase in [Ca2+]i. An unexpected
finding was that the magnitude and time-dependent pattern of
[Ca2+]i changes produced by Ang II were
similar in cells that lacked AT1A receptors but possessed
AT1B receptors. The response in mutant cells indicates
effective coupling of an Ang II receptor to one or more second
messenger systems. The similarity of response patterns between cells
with and without AT1A receptors suggests that
non-AT1A receptors are functionally linked to similar
signal transduction pathways in mutant cells. The fact that mutant and
wild-type cells exhibit similar patterns of calcium mobilization and
entry supports the notion that AT1A and
non-AT1A receptors share common signal transduction
pathways. The AT2 receptor ligands PD-123319 and CGP-42112
do not alter Ang II effects in either VSMC type, suggesting a paucity
of AT2 receptors and/or an absence of their linkage to
[Ca2+]i pathways. The nonpeptide
AT1 receptor blocker losartan antagonizes Ang
IIinduced [Ca2+]i increases in both cell
groups, supporting mediation by native AT1B receptors and
effective coupling of this subtype to second messenger systems leading
to calcium entry and mobilization. Our results demonstrate that Ang II
causes calcium signaling in AT1Adeficient VSMCs that is
mediated by an endogenous losartan-sensitive
AT1B receptor.
© 1998 American Heart Association, Inc.
Scientific Contributions
Angiotensin AT1B Receptor Mediates Calcium Signaling in Vascular Smooth Muscle Cells of AT1A ReceptorDeficient Mice
Key Words: muscle, smooth, vascular angiotensin II receptors, angiotensin calcium channels antagonists losartan fura 2
This article has been cited by other articles:
![]() |
X. C. Li, L. G. Navar, Y. Shao, and J. L. Zhuo Genetic deletion of AT1a receptors attenuates intracellular accumulation of ANG II in the kidney of AT1a receptor-deficient mice Am J Physiol Renal Physiol, August 1, 2007; 293(2): F586 - F593. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Park, B. J. Bivona, and L. M. Harrison-Bernard Compromised renal microvascular reactivity of angiotensin type 1 double null mice Am J Physiol Renal Physiol, July 1, 2007; 293(1): F60 - F67. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. C. Li and J. L. Zhuo Selective knockdown of AT1 receptors by RNA interference inhibits Val5-ANG II endocytosis and NHE-3 expression in immortalized rabbit proximal tubule cells Am J Physiol Cell Physiol, July 1, 2007; 293(1): C367 - C378. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Zhang, D. Yan Liu, L. Q. Ma, Z. D. Luo, T. B. Cao, J. Zhong, Z. C. Yan, L. J. Wang, Z. G. Zhao, S. J. Zhu, et al. Activation of Transient Receptor Potential Vanilloid Type-1 Channel Prevents Adipogenesis and Obesity Circ. Res., April 13, 2007; 100(7): 1063 - 1070. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, H. Chen, and M. Morris Enhanced osmotic responsiveness in angiotensin AT1a receptor deficient mice: evidence for a role for AT1b receptors Exp Physiol, September 1, 2005; 90(5): 739 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, L. F. Joaquim, V. M. Farah, R. B. Wichi, R. Fazan Jr., H. C. Salgado, and M. Morris Cardiovascular autonomic control in mice lacking angiotensin AT1a receptors Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2005; 288(4): R1071 - R1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Sun, X. Wang, C. E. Wood, and J. R. Cade Genetic AT1A receptor deficiency attenuates cold-induced hypertension Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R433 - R439. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhu, S. Zhu, D. Liu, T. Cao, L. Wang, and M. Tepel Thiazide-Like Diuretics Attenuate Agonist-Induced Vasoconstriction by Calcium Desensitization Linked to Rho Kinase Hypertension, February 1, 2005; 45(2): 233 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Ryan, S. P. Didion, S. Mathur, F. M. Faraci, and C. D. Sigmund Angiotensin II-Induced Vascular Dysfunction Is Mediated by the AT1A Receptor in Mice Hypertension, May 1, 2004; 43(5): 1074 - 1079. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhou, W. P. Dirksen, G. J. Babu, and M. Periasamy Differential vasoconstrictions induced by angiotensin II: role of AT1 and AT2 receptors in isolated C57BL/6J mouse blood vessels Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2797 - H2803. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhou, Y. Chen, W. P. Dirksen, M. Morris, and M. Periasamy AT1b Receptor Predominantly Mediates Contractions in Major Mouse Blood Vessels Circ. Res., November 28, 2003; 93(11): 1089 - 1094. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Harrison-Bernard, A. K. Cook, M. I. Oliverio, and T. M. Coffman Renal segmental microvascular responses to ANG II in AT1A receptor null mice Am J Physiol Renal Physiol, March 1, 2003; 284(3): F538 - F545. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Che and P. K. Carmines Angiotensin II Triggers EGFR Tyrosine Kinase-Dependent Ca2+ Influx in Afferent Arterioles Hypertension, November 1, 2002; 40(5): 700 - 706. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cervenka, V. Horacek, I. Vaneckova, J. A. Hubacek, M. I. Oliverio, T. M. Coffman, and L. G. Navar Essential Role of AT1A Receptor in the Development of 2K1C Hypertension Hypertension, November 1, 2002; 40(5): 735 - 741. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hus-Citharel, N. Bouby, J. Marchetti, D. Chansel, D. Goidin, D. Gourdji, P. Corvol, and C. Llorens-Cortes Desensitization of Type 1 Angiotensin II Receptor Subtypes in the Rat Kidney Endocrinology, November 1, 2001; 142(11): 4683 - 4692. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rapacciuolo, G. Esposito, K. Caron, L. Mao, S. A. Thomas, and H. A. Rockman Important role of endogenous norepinephrine and epinephrine in the development of in vivo pressure-overload cardiac hypertrophy J. Am. Coll. Cardiol., September 1, 2001; 38(3): 876 - 882. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J Arendshorst Review: Lessons on renal function from transgenic mice lacking different angiotensin II receptors Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S167 - S175. [PDF] |
||||
![]() |
R. M. Touyz and E. L. Schiffrin Signal Transduction Mechanisms Mediating the Physiological and Pathophysiological Actions of Angiotensin II in Vascular Smooth Muscle Cells Pharmacol. Rev., December 1, 2000; 52(4): 639 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. de Gasparo, K. J. Catt, T. Inagami, J. W. Wright, and Th. Unger International Union of Pharmacology. XXIII. The Angiotensin II Receptors Pharmacol. Rev., September 1, 2000; 52(3): 415 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Oguchi, P. Dimayuga, J. Zhu, K.-Y. Chyu, J. Yano, P. K. Shah, J. Nilsson, and B. Cercek Monoclonal Antibody Against Vascular Cell Adhesion Molecule-1 Inhibits Neointimal Formation After Periadventitial Carotid Artery Injury in Genetically Hypercholesterolemic Mice Arterioscler Thromb Vasc Biol, July 1, 2000; 20(7): 1729 - 1736. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D Hughes AT 1-signalling in vascular smooth muscle Journal of Renin-Angiotensin-Aldosterone System, June 1, 2000; 1(2): 125 - 130. [PDF] |
||||
![]() |
F. M. Faraci and C. D. Sigmund Vascular Biology in Genetically Altered Mice : Smaller Vessels, Bigger Insight Circ. Res., December 3, 1999; 85(12): 1214 - 1225. [Full Text] [PDF] |
||||
![]() |
X. RUAN, M. I. OLIVERIO, T. M. COFFMAN, and W. J. ARENDSHORST Renal Vascular Reactivity in Mice: AngII-Induced Vasoconstriction inAT1A Receptor Null Mice J. Am. Soc. Nephrol., December 1, 1999; 10(12): 2620 - 2630. [Abstract] [Full Text] |
||||
![]() |
D. E. Dostal and K. M. Baker The Cardiac Renin-Angiotensin System : Conceptual, or a Regulator of Cardiac Function? Circ. Res., October 1, 1999; 85(7): 643 - 650. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |